Statlife receives 510(k) clearance from the FDA for DenSeeMammo™

Doctor, what is my risk of developing breast cancer?

MammoRisk assesses breast cancer risk in women over 40

MammoRisk is the ONLY risk assessment tool using BREAST DENSITY

MammoRisk is a state-of-the-art tool for assessing breast cancer risk. It is designed for imaging centers and breast health centers.

MammoRisk uses a risk prediction model based on data mining to assess a woman’s risk of developing
breast cancer.

DenSeeMammo measures breast density which is a determining risk factor for women over 40.

MammoRisk reports are readily accessible and easy to understand for the clinician to discuss with the patient.

MammoRisk software provides an individualized breast cancer screening plan based on current screening guidelines.